trial · primary record
IEV407
Advanced HR+/HER2- Breast Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 194 |
| Primary completion | 2032-06-08 |
| Primary endpoint | Incidence and severity of dose-limiting toxicities (DLTs) |
| Registry ID | NCT07604571 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:12.263Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07604571
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.